Next Article in Journal
TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation Status
Next Article in Special Issue
Anti-Cancer Stem-Cell-Targeted Therapies in Prostate Cancer
Previous Article in Journal
A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix® PC1 System
 
 
Article

Article Versions Notes

Cancers 2022, 14(21), 5239; https://doi.org/10.3390/cancers14215239
Action Date Notes Link
article xml file uploaded 26 October 2022 09:35 CEST Original file -
article xml uploaded. 26 October 2022 09:35 CEST Update https://www.mdpi.com/2072-6694/14/21/5239/xml
article pdf uploaded. 26 October 2022 09:35 CEST Version of Record https://www.mdpi.com/2072-6694/14/21/5239/pdf
article supplementary file uploaded. 26 October 2022 09:35 CEST - https://www.mdpi.com/2072-6694/14/21/5239#supplementary
article html file updated 26 October 2022 09:36 CEST Original file -
article html file updated 28 February 2023 19:53 CET Update -
article html file updated 2 March 2023 00:27 CET Update https://www.mdpi.com/2072-6694/14/21/5239/html
Back to TopTop